Here are five key notes on the company’s financial report:
1. Revenue was up 30 percent to $18.4 million in the third quarter. Pathology revenue was up 23 percent.
2. International revenue grew 188 percent year-over-year and is now 12 percent of total revenue.
3. Gross profit hits $6.1 million, 33.4 percent over the same period last year.
4. Net loss for the quarter was $11.6 million, or $0.47 per share.
5. Total revenue is expected to reach $72 million to $74 million for the full year. Net loss is projected at$60 million to $61 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.